Matthew Krebs

On completion of his PhD, he was awarded a Clinical Lectureship by the National Institute for Health Research to further develop laboratory expertise at the University of Manchester, alongside completion of clinical training. His research, with Professor Caroline Dive, focused on establishing methods for genetic profiling of cancer cells and circulating DNA in the blood. In June 2014, he was appointed to his current position as Clinical Senior Lecturer in Experimental Cancer Medicine at The Christie and University of Manchester. He undertakes early-phase clinical trials of new anti-cancer drugs, and researches the use of blood tests to help guide treatment selection and monitor treatment response. He is a member of the Manchester Experimental Cancer Medicine Steering Board, and deputises as clinical trials theme lead within the Manchester-UCL Lung Cancer Centre of Excellence.